RIO DE JANEIRO, BRAZIL – The Brazilian Health Regulatory Agency (ANVISA) on Wednesday, February 16, received a request from U.S. pharmaceutical company Pfizer for the emergency use of Paxlovid, a drug to treat Covid-19, the regulator reported.
Paxlovid is currently in use in the United States, China, Canada, Japan, and European Union countries. The data presented by the laboratory that the drug can reduce hospitalization and deaths by up to 89% when administered early in the infection will now be reviewed by ANVISA.
The deadline for the assessment of the request will be 30 days, and within 24 hours “the documents submitted will be reviewed to ensure that they are in compliance with the required information,” and the technical analysis of the antiviral drug for oral use will begin.
More: Brazil news in English, every day from The Rio Times.
This article was produced by The Rio Times’ automated AI newsroom. Editorial responsibility: Matthias Camenzind, Publisher and Editor-in-Chief. The Rio Times also runs Ask Rio Times, which answers from 100,000+ of our own articles, the daily Latin America Power Map, and prediction-market odds on elections and markets.. How we use AI · Report an error
Brazil runoff, Sunday, October 25: Brazil runoff: date, poll closing times and when results start. Latest: Brazil runoff polls, Flávio 51%, Lula 49%.